An Update on Hepatic Arterial Infusion Chemotherapy for Colorectal Cancer

An Update on Hepatic Arterial Infusion Chemotherapy for Colorectal Cancer Adam D. Cohen, Nancy E. Kemeny Oncologist 2003; 8: 553-566 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in hepatobiliary and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Explain the rationale for using HAI chemotherapy in patients with isolated liver metastases from colorectal cancer. Summarize the data from randomized clinical trials using HAI chemotherapy in patients with both unresectable and resectable metastases. Describe current approaches combining HAI chemotherapy with newer systemic chemotherapeutic or biologic agents. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Dec. 03, 2003 Most Recent Review: June 10, 2005* Most Recent Update: Dec. 03, 2003 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.